On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis
Osteoarthritis (OA) is one of the leading causes of disability in the world, but the efficacy and safety of its treatment remain extremely low. This review presents epidemiology of OA, mechanism of its development and modern possibilities of pharmacological regulation of immune-mediated inflammation...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IMA-PRESS LLC
2024-08-01
|
| Series: | Современная ревматология |
| Subjects: | |
| Online Access: | https://mrj.ima-press.net/mrj/article/view/1630 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849744291339960320 |
|---|---|
| author | I. V. Sarvilina A. M. Lila O. A. Gromova |
| author_facet | I. V. Sarvilina A. M. Lila O. A. Gromova |
| author_sort | I. V. Sarvilina |
| collection | DOAJ |
| description | Osteoarthritis (OA) is one of the leading causes of disability in the world, but the efficacy and safety of its treatment remain extremely low. This review presents epidemiology of OA, mechanism of its development and modern possibilities of pharmacological regulation of immune-mediated inflammation in OA. We analyze the immunological aspects of oral tolerance phenomenon and the prospects for its use to suppress autoinflammation in OA using combined pharmaconutraceutical preparation Chondroguard® TRIO as an element of nutritional support for patients with this disease. It is emphasized that it is advisable to develop a scientifically based rational approach to the treatment of OA that alleviates symptoms, reduces autoinflammatory affection of articular cartilage and improves its regeneration with the involvement of extracellular matrix components. |
| format | Article |
| id | doaj-art-b4554a1819df459f8e3aba67ab7bbf42 |
| institution | DOAJ |
| issn | 1996-7012 2310-158X |
| language | Russian |
| publishDate | 2024-08-01 |
| publisher | IMA-PRESS LLC |
| record_format | Article |
| series | Современная ревматология |
| spelling | doaj-art-b4554a1819df459f8e3aba67ab7bbf422025-08-20T03:20:58ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2024-08-0118412112710.14412/1996-7012-2024-4-121-1272712On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritisI. V. Sarvilina0A. M. Lila1O. A. Gromova2LLC "Medical Center" Novomeditsina"V.A. Nasonova Research Institute of Rheumatology; Russian Medical Academy of Continuing Professional EducationFederal Research Center "Informatics and Management"Osteoarthritis (OA) is one of the leading causes of disability in the world, but the efficacy and safety of its treatment remain extremely low. This review presents epidemiology of OA, mechanism of its development and modern possibilities of pharmacological regulation of immune-mediated inflammation in OA. We analyze the immunological aspects of oral tolerance phenomenon and the prospects for its use to suppress autoinflammation in OA using combined pharmaconutraceutical preparation Chondroguard® TRIO as an element of nutritional support for patients with this disease. It is emphasized that it is advisable to develop a scientifically based rational approach to the treatment of OA that alleviates symptoms, reduces autoinflammatory affection of articular cartilage and improves its regeneration with the involvement of extracellular matrix components.https://mrj.ima-press.net/mrj/article/view/1630osteoarthritisoral toleranceundenatured collagen type iichondroitin sulfateglucosamine sulfate |
| spellingShingle | I. V. Sarvilina A. M. Lila O. A. Gromova On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis Современная ревматология osteoarthritis oral tolerance undenatured collagen type ii chondroitin sulfate glucosamine sulfate |
| title | On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| title_full | On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| title_fullStr | On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| title_full_unstemmed | On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| title_short | On the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| title_sort | on the immunotropic effects of a new combined pharmaconutraceutical preparation in osteoarthritis |
| topic | osteoarthritis oral tolerance undenatured collagen type ii chondroitin sulfate glucosamine sulfate |
| url | https://mrj.ima-press.net/mrj/article/view/1630 |
| work_keys_str_mv | AT ivsarvilina ontheimmunotropiceffectsofanewcombinedpharmaconutraceuticalpreparationinosteoarthritis AT amlila ontheimmunotropiceffectsofanewcombinedpharmaconutraceuticalpreparationinosteoarthritis AT oagromova ontheimmunotropiceffectsofanewcombinedpharmaconutraceuticalpreparationinosteoarthritis |